JBM Healthcare Announces FY2024 Interim Results
Net Profit Triples to HK$62.5 MillionInterim Dividend of HK3.45 cents per shareStrong Revenue Growth and Improved MarginsDriven by Effective Brand Management Strategies Amid Market Recovery HONG KONG, Nov 22, 2023 - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). KEY HIGHLIGHTS -- Revenue up by 38.0% to HK$326.8 million -- Gro...